Skip Navigation

Annals of Oncology 2005 16(1):34-37; doi:10.1093/annonc/mdi032
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow A corrigendum has been published
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patnick, J.
Right arrow Articles by Smith, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patnick, J.
Right arrow Articles by Smith, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Special article

Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)

J. Patnick1,{dagger}, D. Ransohoff2,{dagger}, W. Atkin3,{ddagger}, J. Ma Borras4, M. Elwood5, G. Hoff6, M. Nadel7, A. Russo8, J. Simon9, E. Weiderpass-Vaino10, M. Zappa11 and R. Smith12,*

1 The Manor House, Sheffield, UK; 2 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 3 Cancer Research UK, London, UK; 4 Institut Català d'Oncologia, Barcelona, Spain; 5 National Cancer Control Initiative, Melbourne, Australia; 6 Institute of Population-based Cancer Research, Oslo, Norway; 7 Centers for Disease Control and Prevention, Atlanta, GA, USA; 8 Local Health Authority of Milan, Milan, Italy; 9 Queen's University, Kingston, Canada; 10 International Agency for Research on Cancer, Lyon, France; 11 Center for Study and Prevention of Cancer, Florence, Italy; 12 American Cancer Society, Atlanta, GA, USA

* Correspondence to: Dr R. Smith, American Cancer Society, 1599 Clifton Road NE, Atlanta, GA 30329, USA. Tel: +1-404-329-7610; Email: Robert.Smith@cancer.org

The first 150 words of the full text of this article appear below.


   Introduction
 
All screening programs involve a trade-off between benefits, limitations and risks [1Go–3Go]. Quality assurance efforts and program evaluation are intended to ensure that these competing elements are kept in balance, by helping to maximize benefit and minimize risk. In the case of screening for colorectal cancer, this means maximizing the potential mortality reduction while minimizing the undesirable side effects of screening, such as the potential morbidity associated with colonoscopy. In order to achieve this potential, attention to quality assurance is among the chief prerequisites for successful screening programs. The elements of a quality assurance program must be understood and appreciated, and be monitored over both the short- and long-term and linked with program outcomes. Quality assurance requirements will vary with the mode of screening for colorectal cancer that is under consideration.

The Workshop mainly considered population-based screening of asymptomatic individuals, and recognized that a population could be defined . . . [Full Text of this Article]


   Key issues, barriers and challenges, and recommendations
 
A. Assessing safety and thoroughness of the screening process
B. Comparing results from different screening settings to learn about effectiveness and cost
C. Selected major issues relating to quality assurance

   Summary
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?